دورية أكاديمية
أعرض في EDS

Impact of tobacco smoking on disease-specific outcomes in common neurological disorders: A scoping review.

التفاصيل البيبلوغرافية
العنوان: Impact of tobacco smoking on disease-specific outcomes in common neurological disorders: A scoping review.
المؤلفون: Wahbeh F; Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute and Department of Neurology, Weill Cornell Medicine, New York, NY, USA., Restifo D; Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute and Department of Neurology, Weill Cornell Medicine, New York, NY, USA., Laws S; Education and Research, Health Sciences Library, Weill Cornell Medicine - Qatar, Doha, Qatar., Pawar A; Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute and Department of Neurology, Weill Cornell Medicine, New York, NY, USA., Parikh NS; Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute and Department of Neurology, Weill Cornell Medicine, New York, NY, USA. Electronic address: nsp2001@med.cornell.edu.
المصدر: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia [J Clin Neurosci] 2024 Apr; Vol. 122, pp. 10-18. Date of Electronic Publication: 2024 Feb 29.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Churchill Livingstone Country of Publication: Scotland NLM ID: 9433352 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2653 (Electronic) Linking ISSN: 09675868 NLM ISO Abbreviation: J Clin Neurosci Subsets: MEDLINE
أسماء مطبوعة: Publication: <2000->: Edinburgh : Churchill Livingstone
Original Publication: Melbourne, Vic., Australia : Churchill Livingstone, c1994-
مواضيع طبية MeSH: Smoking Cessation* , Stroke*/epidemiology , Stroke*/etiology , Stroke*/therapy , Multiple Sclerosis*, Humans ; Smoking/adverse effects ; Smoking/epidemiology ; Tobacco Smoking
مستخلص: Although the association of smoking with the risk of incident neurological disorders is well established, less is known about the impact of smoking and smoking cessation on outcomes of these conditions. The objective of this scoping review was to synthesize what is known about the impact of smoking and smoking cessation on disease-specific outcomes for seven common neurological disorders. We included 67 studies on the association of smoking and smoking cessation on disease-specific outcomes. For multiple sclerosis, smoking was associated with greater clinical and radiological disease progression, relapses, risk for disease-related death, cognitive decline, and mood symptoms, in addition to reduced treatment effectiveness. For stroke and transient ischemic attack, smoking was associated with greater rates of stroke recurrence, post-stroke cardiovascular outcomes, post-stroke mortality, post-stroke cognitive impairment, and functional impairment. In patients with cognitive impairment and dementia, smoking was associated with faster cognitive decline, and smoking was also associated with greater cognitive decline in Parkinson's disease, but not motor symptom worsening. Patients with amyotrophic lateral sclerosis who smoked faced increased mortality. Last, in patients with cluster headache, smoking was associated with more frequent and longer cluster attack periods. Conversely, for multiple sclerosis and stroke, smoking cessation was associated with improved disease-specific outcomes. In summary, whereas smoking is detrimentally associated with disease-specific outcomes in common neurological conditions, there is growing evidence that smoking cessation may improve outcomes. Effective smoking cessation interventions should be leveraged in the management of common neurological disorders to improve patient outcomes.
Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Dr. N. Parikh has received personal fees for medicolegal consulting and provides blinded end point assessment for the Embolization of the Middle Meningeal Artery with ONYX Liquid Embolic System for Subacute and Chronic Subdural Hematoma trial (Medtronic) for participants enrolled at his institution. Dr. N. Parikh was supported by the NIH/NIA (K23 AG073524) and Florence Gould Endowment for Discovery in Stroke. There are no direct relationships between these interests and the topic of this manuscript.
(Copyright © 2024 Elsevier Ltd. All rights reserved.)
References: Mult Scler. 2008 Sep;14(8):1026-30. (PMID: 18632775)
J Stroke Cerebrovasc Dis. 2013 Oct;22(7):e59-65. (PMID: 22578918)
Eur J Neurol. 2017 Apr;24(4):624-630. (PMID: 28239937)
Nicotine Tob Res. 2016 Aug;18(8):1684-96. (PMID: 26783291)
JAMA Netw Open. 2020 Oct 1;3(10):e2018777. (PMID: 33006621)
Stroke. 2001 Feb;32(2):485-91. (PMID: 11157187)
N Engl J Med. 2018 Jun 07;378(23):2182-2190. (PMID: 29766771)
BMJ. 2015 Apr 20;350:h1551. (PMID: 25896935)
Cerebrovasc Dis. 2007;23(2-3):117-20. (PMID: 17124391)
Arch Gerontol Geriatr. 2023 Jan;104:104841. (PMID: 36265390)
Stroke. 2015 Jan;46(1):42-8. (PMID: 25395411)
Stroke. 2014 Jul;45(7):1958-63. (PMID: 24851875)
Parkinsonism Relat Disord. 2007 May;13(4):243-5. (PMID: 17275394)
J Stroke Cerebrovasc Dis. 2019 Aug;28(8):2232-2241. (PMID: 31178360)
Lancet Public Health. 2022 Jan;7(1):e74-e85. (PMID: 34756176)
Stroke. 2013 Sep;44(9):2414-21. (PMID: 23868274)
J Alzheimers Dis. 2022;86(4):1897-1906. (PMID: 35253766)
Eur J Neurol. 2008 Nov;15(11):1245-51. (PMID: 18973614)
Brain. 2013 Jul;136(Pt 7):2298-304. (PMID: 23757766)
Implement Sci Commun. 2021 Apr 9;2(1):41. (PMID: 33836840)
J Stroke Cerebrovasc Dis. 2016 Mar;25(3):656-64. (PMID: 26750575)
Neurol Neuroimmunol Neuroinflamm. 2016 Jul 14;3(4):e260. (PMID: 27458599)
BMJ. 2014 Feb 13;348:g1151. (PMID: 24524926)
Brain. 2005 Jun;128(Pt 6):1461-5. (PMID: 15758034)
Acta Neurol Scand. 2019 Oct;140(4):281-289. (PMID: 31265131)
Stroke. 2020 Mar;51(3):846-852. (PMID: 31896344)
Stroke. 2023 Apr;54(4):921-927. (PMID: 36876480)
Mov Disord. 2002 Mar;17(2):250-7. (PMID: 11921109)
Stroke. 2020 Jun;51(6):1865-1867. (PMID: 32390546)
J Gerontol Nurs. 2020 Aug 1;46(8):28-36. (PMID: 32936925)
Mov Disord. 2019 Jan;34(1):58-66. (PMID: 30653734)
J Alzheimers Dis. 2017;56(2):575-584. (PMID: 28035932)
Ochsner J. 2022 Summer;22(2):129-133. (PMID: 35756598)
Compr Psychiatry. 2017 Oct;78:91-97. (PMID: 28806610)
J Neurol. 2018 May;265(5):1010-1015. (PMID: 29464378)
Stroke. 2020 Jun;51(6):1656-1661. (PMID: 32390553)
J Stroke Cerebrovasc Dis. 2019 Feb;28(2):267-275. (PMID: 30385221)
N Engl J Med. 2019 Feb 7;380(6):512-515. (PMID: 30601710)
Mult Scler Relat Disord. 2021 May;50:102801. (PMID: 33636616)
Arterioscler Thromb Vasc Biol. 2014 Mar;34(3):509-15. (PMID: 24554606)
Neurology. 2018 Feb 13;90(7):e593-e600. (PMID: 29343473)
Nicotine Tob Res. 2018 Apr 2;20(5):589-595. (PMID: 28402456)
Lancet Neurol. 2010 Jul;9(7):727-39. (PMID: 20610348)
PLoS One. 2013;8(1):e53996. (PMID: 23320113)
J Neurol Sci. 2016 Nov 15;370:219-223. (PMID: 27772763)
JAMA. 2021 Jan 19;325(3):265-279. (PMID: 33464343)
Cancer Epidemiol Biomarkers Prev. 2014 Jan;23(1):3-9. (PMID: 24420982)
J Headache Pain. 2013 Jun 06;14:48. (PMID: 23742010)
Neurology. 2017 Oct 17;89(16):1723-1729. (PMID: 28887378)
Ann Intern Med. 2018 Oct 2;169(7):467-473. (PMID: 30178033)
Eur J Prev Cardiol. 2013 Jun;20(3):486-95. (PMID: 21968571)
Geriatr Gerontol Int. 2021 Jan;21(1):43-47. (PMID: 33260269)
Neurology. 2020 May 5;94(18):e1950-e1960. (PMID: 32300060)
PLoS One. 2015 Mar 12;10(3):e0118333. (PMID: 25763939)
Arq Neuropsiquiatr. 2021 Jun;79(6):489-496. (PMID: 34320054)
Mult Scler. 2019 Aug;25(9):1298-1305. (PMID: 30070595)
Arch Med Res. 2017 Jan;48(1):113-120. (PMID: 28577864)
JAMA Oncol. 2023 Jul 1;9(7):981-1000. (PMID: 37103911)
Eur Respir J. 2008 Oct;32(4):844-53. (PMID: 18827152)
Arch Neurol. 2009 Jul;66(7):858-64. (PMID: 19597087)
Mov Disord. 2004 Sep;19(9):1087-1092. (PMID: 15372603)
Neurol Clin Pract. 2023 Feb;13(1):e200115. (PMID: 36865635)
J Am Heart Assoc. 2019 Apr 16;8(8):e011696. (PMID: 30955409)
Mult Scler. 2014 Apr;20(4):445-50. (PMID: 23924603)
Mult Scler. 2014 Jul;20(8):1081-5. (PMID: 24311118)
J Stroke Cerebrovasc Dis. 2013 Nov;22(8):e446-54. (PMID: 23759136)
Neurology. 2017 Sep 26;89(13):1408-1415. (PMID: 28855408)
J Neurol. 2022 Mar;269(3):1663-1669. (PMID: 34392376)
J Stroke Cerebrovasc Dis. 2013 Aug;22(6):792-8. (PMID: 22633681)
Neurol Neuroimmunol Neuroinflamm. 2022 Jun 23;9(5):. (PMID: 35738901)
Neurology. 2005 Apr 12;64(7):1301-3. (PMID: 15824373)
Stroke. 2023 Mar;54(3):e63-e65. (PMID: 36727507)
Int J Neurosci. 2013 Jul;123(7):476-9. (PMID: 23302010)
Am J Epidemiol. 2012 Aug 1;176(3):233-9. (PMID: 22791740)
JAMA. 2019 Aug 20;322(7):642-650. (PMID: 31429895)
Clin Rehabil. 2003 Mar;17(2):158-66. (PMID: 12625656)
J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1091-5. (PMID: 24569687)
Mult Scler Relat Disord. 2021 Sep;54:103115. (PMID: 34216997)
Acta Neurol Scand. 2010 Sep;122(3):217-23. (PMID: 20078446)
Neurol Clin Pract. 2012 Jun;2(2):112-121. (PMID: 29443310)
MethodsX. 2021 May 07;8:101375. (PMID: 34430271)
Stroke. 2022 Apr;53(4):1285-1291. (PMID: 34784739)
BMC Neurol. 2010 Jan 14;10:6. (PMID: 20074360)
Geriatr Nurs. 2021 Jan-Feb;42(1):268-275. (PMID: 32919799)
J Psychosom Res. 2015 Aug;79(2):143-7. (PMID: 25868687)
Lancet Neurol. 2019 May;18(5):459-480. (PMID: 30879893)
Brain. 2022 May 24;145(4):1368-1378. (PMID: 34623418)
Neurology. 2015 Nov 10;85(19):1694-701. (PMID: 26453645)
Mult Scler J Exp Transl Clin. 2020 Oct 13;6(4):2055217320959815. (PMID: 33110616)
Stroke. 2023 Apr;54(4):992-1000. (PMID: 36866670)
J Neurol. 2009 Apr;256(4):577-85. (PMID: 19365595)
Aging (Albany NY). 2021 Feb 12;13(4):6205-6213. (PMID: 33578392)
Mult Scler J Exp Transl Clin. 2020 Jan 27;6(1):2055217320902488. (PMID: 32064117)
Lancet. 2021 Jun 19;397(10292):2337-2360. (PMID: 34051883)
معلومات مُعتمدة: K23 AG073524 United States AG NIA NIH HHS
فهرسة مساهمة: Keywords: Neurological disorders; Risk factors; Smoking cessation; Tobacco smoking
تواريخ الأحداث: Date Created: 20240301 Date Completed: 20240329 Latest Revision: 20240330
رمز التحديث: 20240330
مُعرف محوري في PubMed: PMC10978265
DOI: 10.1016/j.jocn.2024.02.013
PMID: 38428126
قاعدة البيانات: MEDLINE
الوصف
تدمد:1532-2653
DOI:10.1016/j.jocn.2024.02.013